- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 211
AutoDesk-backed eSub builds $12m series B
The construction management software provider secured $12m in a round led by growth equity investor Catalyst Investors.
May 31, 2019Mudu.tv streams in Yonyou series B investment
Yonyou Network Technology has supplied $15.9m for the livestreaming services provider that will fund the development of AI and big data technology.
May 31, 2019Crazy Dog retrieves series B funding
Fosun co-led a $43.4m round for omnichannel petcare brand Crazy Dog that will support an expansion slated to include the opening of offline stores.
May 30, 2019Ayala aligns with corporates for $30m series B
The cancer drug developer has closed a series B round led by development partner Novartis that included Harel Insurance and Finance and SBI JI Innovation Fund.
May 30, 2019Google returns for KaiOS in $50m series B
Existing backer Google has reinvested in the mobile operating system developer to increase its overall funding to $79m.
May 28, 2019Cardinal Analytx ticks off $23m series B
GuideWell Mutual, Blue Shield California and existing backer Premera Blue Cross all invested in the healthcare prediction platform developer based on Stanford research.
May 28, 2019AlloVir secures $120m funding allocation
The T-Cell therapy developer, based on research at Baylor College of Medicine, has received funding in a Gilead Sciences-backed series B round led by Fidelity Management and Research.
May 28, 2019Corporate venturing deal net: 20-24 May 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
May 24, 2019Pixie Dust cleans up with series B funding
Pixie Dust Technologies, which promotes university-derived technologies from Japan, has received $34.7m in a round that included KDDI, Kansai Electric Power, NEC, Toppan, Dai-ichi Life and Dentsu.
May 24, 2019AlloVir secures $120m funding allocation
The T-Cell therapy developer has received funding in a Gilead Sciences-backed series B round led by Fidelity Management and Research.
May 24, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


